<?xml version="1.0" encoding="UTF-8"?>
<p id="Par50">The other modes of vaccine development are the utilization of either the virus itself or its part for developing whole organism-based vaccines or subunit vaccines. These include attenuated or inactivated vaccines using cultured SARS-CoV-2 that can be mitigated by passaging or inactivated by physical and chemical methods such as UV light, formaldehyde, and Î²-propiolactone [
 <xref ref-type="bibr" rid="CR201">201</xref>]. However, these may have limitations of infectivity, reversion to pathogenicity, and disease-causing potential [
 <xref ref-type="bibr" rid="CR218">218</xref>].
</p>
